| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.116 | 8.317 | 12.959 | 16.713 | 21.523 | 29.955 | 29.729 | 31.969 | 25.721 | 19.871 |
| Total Income - EUR | 5.116 | 8.317 | 12.959 | 16.713 | 21.523 | 29.955 | 29.729 | 31.969 | 25.721 | 19.871 |
| Total Expenses - EUR | 2.206 | 2.232 | 3.396 | 4.133 | 12.198 | 12.619 | 13.603 | 14.428 | 17.054 | 25.641 |
| Gross Profit/Loss - EUR | 2.910 | 6.085 | 9.563 | 12.580 | 9.325 | 17.337 | 16.126 | 17.541 | 8.666 | -5.771 |
| Net Profit/Loss - EUR | 2.757 | 5.901 | 9.309 | 12.078 | 8.679 | 16.634 | 15.436 | 16.776 | 7.206 | -5.771 |
| Employees | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Reladmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.217 | 1.204 | 1.184 | 1.162 | 33.689 | 29.785 | 24.963 | 20.289 | 54.609 | 46.249 |
| Current Assets | 2.960 | 243 | 416 | 890 | 3.178 | 19.443 | 36.346 | 37.460 | 10.804 | 8.412 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 729 | 0 | 146 | 1 | 1 | 2.646 | 607 |
| Cash | 2.960 | 243 | 416 | 162 | 3.178 | 19.298 | 36.344 | 37.460 | 8.158 | 7.805 |
| Shareholders Funds | -27.838 | -21.653 | -11.978 | 320 | 8.993 | 25.457 | 40.328 | 57.027 | 64.060 | 53.561 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 32.014 | 23.101 | 13.578 | 1.732 | 27.874 | 23.771 | 20.980 | 723 | 1.353 | 1.100 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Reladmed Srl